(Bloomberg) — A dual-listed British biotechnology firm with a U.S. ticker that could be mistaken for Tesla Inc. has more than tripled in New York trading this year.
Tiziana Life Sciences Plc has drawn increased interest from retail investors amid the electric automaker’s meteoric rise, as seen by the jump in Robinhood accounts holding American depositary receipts of the drug developer, according to Robintrack.net. Tiziana’s ADRs trade on the Nasdaq under the ticker “TLSA,” and even some media publications have at times mistaken them for Tesla shares, which trade under “TSLA.”
More at: finance.yahoo.com/news/tesla-ticker-confusion-may-aiding-174002345.html
Views: